Hims & Hers is taking aim at menopause and perimenopause in an attempt to tap in to a huge and potentially highly lucrative market.
www.marketwatch.com
#Weightloss #drugs #shook #stock #market #Menopause #treatments
Related Posts

Lower rates in time for holiday cash needs
The current national average HELOC rate is falling to new 2025 lows, according to the analytics company Curinos. Home equity…

Infosys Limited (INFY) Collaborates With Anthropic
Infosys Limited (NYSE:INFY) is one of the 11 best 52-week low technology stocks to buy now. On February 17, Infosys…

Opendoor Stock Is Surging Higher in a Frenzied Retail Rally. How Should You Play OPEN Shares Here?
Getting keys to a house by AndreyPopov via iStock Opendoor (OPEN) shares soared more than 100% on Monday as retail…

